Login / Signup

Orally dissolving buprenorphine for opioid use disorder linked to caries.

Stuart L SegelnickMea A Weinberg
Published in: Journal of the American Dental Association (1939) (2024)
It is imperative for dentists to recognize buprenorphine as medication-assisted treatment and to recognize a patient as having an OUD. While taking buprenorphine, the patient should have more frequent oral health care appointments, including home care instructions and caries risk assessment to monitor for caries and xerostomia so that treatment, if indicated, could be initiated as soon as possible. In addition, the dentist's role in OUD is to make sure patients follow the treatment recommendations and use the buprenorphine and to not have them discontinue because of potential caries risk.
Keyphrases
  • healthcare
  • risk assessment
  • end stage renal disease
  • case report
  • chronic kidney disease
  • oral health
  • newly diagnosed
  • climate change
  • prognostic factors
  • social media